Table 1 Baseline characteristics in cancer patients who underwent pericardial window for non-malignant and malignant pericardial effusions
From: Persistent PR segment change in malignant pericardial disease
Non-malignant effusion, n = 18 (%) | Malignant effusion, n = 8 (%) | p-value | |
|---|---|---|---|
Age (years) | 57.94 [19, 71] | 54 [30, 69] | 0.27 |
Male | 11 (61.1) | 3 (37.5) | 0.40 |
Malignancy | |||
Lung | 8 (44.4) | 5 (62.5) | 0.67 |
Breast | 1 (5.56) | 1 (12.5) | 0.53 |
Leukemia | 5 (27.8) | 0 (0) | 0.28 |
Hodgkin’s | 3 (16.7) | 0 (0) | 0.53 |
Head & Neck | 0 (0) | 1 (12.5) | 0.31 |
Myelodysplastic Syndrome | 1 (5.56) | 0 (0) | 1.00 |
Other | 2 (11.1) | 1 (12.5) | 1.00 |
Treatment | |||
Chemotherapy | 16 (88.9) | 7 (87.5) | 1.00 |
Chemotherapy + | 6 (33.3) | 1 (12.5) | 0.37 |
Chest Radiation | |||
Bone Marrow Transplant | 3 (16.7) | 0 (0) | 0.53 |
Co-morbidities | |||
Hypertension | 8 (44.4) | 2 (25) | 1.00 |
Dyslipidemia | 7 (38.9) | 1 (12.5) | 0.36 |
Coronary Artery Disease | 2 (11.1) | 0 (0) | 1.00 |
Pulmonary Embolism | 3 (16.7) | 3 (37.5) | 0.33 |
Diabetes Mellitus | 7 (38.9) | 0 (0) | 0.06 |
Paroxysmal Atrial Fibrillation | 7 (38.9) | 1 (12.5) | 0.36 |
History of myopericarditis | 1 (5.56) | 3 (37.5) | 0.07 |
Chronic obstructive pulmonary disease | 3 (16.7) | 1 (12.5) | 1.00 |
Sepsis | 2 (11.1) | 0 (0) | 1.00 |
Connective Tissue Disease | 1 (5.56) | 1 (12.5) | 0.53 |
Chronic Kidney Disease | 1 (5.56) | 0 (0) | 1.00 |
Other infection | 1 (5.56) | 0 (0) | 1.00 |
Indication | 1.00 | ||
Cardiac tamponade | 10 (55.6) | 7 (87.5) | 0.19 |
Impending cardiac tamponade | 8 (44.4) | 1 (12.5) | 0.19 |
Pericardial effusion | 3 (16.7) | 0 (0) | 0.53 |
Heart rate (beats per minute) | 101 [76, 128] | 108 [88, 128] | 0.25 |
ECG | <0.001 | ||
Positive* | 0 (0) | 8 (100) | |
Negative** | 18 (100) | 0 (0) | |
Pathology | <0.001 | ||
Positive | 0 (0) | 8 (100) | |
Negative | 18 (100) | 0 (0) |